<SEC-DOCUMENT>0001104659-16-154928-index.html : 20161104 <SEC-HEADER>0001104659-16-154928.hdr.sgml : 20161104 <ACCEPTANCE-DATETIME>20161104163421 ACCESSION NUMBER: 0001104659-16-154928 CONFORMED SUBMISSION TYPE: F-3/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20161104 DATE AS OF CHANGE: 20161104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-214197 FILM NUMBER: 161975602 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 </SEC-HEADER> <DOCUMENT> <TYPE>F-3/A <SEQUENCE>1 <FILENAME>a16-20255_3f3a.htm <DESCRIPTION>F-3/A <TEXT> Document 1 - file: a16-20255_3f3a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>a16-20255_3ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: a16-20255_3ex5d1.htm
</DOCUMENT> </SEC-DOCUMENT>